Barr Laboratories (BRL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Barr Laboratories (BRL)

An SI Board Since December 2003

Posts	SubjectMarks	Bans	Symbol
10	2	0	BRL

Emcee: A.J. Mullen	Type: Moderated

Introduction Market Data Compact

I think it's about time Barr had its own thread.

They are a generic manufacturer differentiating themselves by carving out a niche in women's reproductive health. They recently introduced an oral contraceptive that is designed to extend periods from one month to one year. More recently still, and more controversially, this is the company that has applied for permission to market sell "Plan B", the "morning after pill" over the counter.

I like the idea of having a generic manufacturer in my portfolio as a hedge. More controls on health spending should be good for generics. I think "Seasonale" might be attractive to many women, and if "Plan B" gets approved then surely its sales will increase.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
10	Press Release Source: Barr Pharmaceuticals, Inc. Barr Exercises Royalty Option	A.J. Mullen	-	9/16/2004
9	Barr Pharma Down on FDA Ruling <i> {But not by much <AJM><	A.J. Mullen	-	5/7/2004
8	Drug Makers Use New Tactic To Ding Generic-Drug Firms By LEILA ABBOUD Staff Re	A.J. Mullen	-	1/27/2004
7	Barr Receives Tentative Approval for Modafinil Tablets, 100 mg and 200 mg Thur	A.J. Mullen	-	1/8/2004
6	Glad to hear from you. It's good to know I'll not be posting to a void	A.J. Mullen	-	1/6/2004
5	I've owned Barr shares since April 1995. My longest continuous holding. On	rkrw	-	1/5/2004
4	Barr Receives Approval for and Launches Mirtazapine Orally Disintegrating Tablet	A.J. Mullen	-	12/18/2003
3	FDA Advisory Committees Vote to Allow Over-the-Counter Sale of Emergency Contrac	A.J. Mullen	-	12/17/2003
2	Barr stirs controversy with 'Plan B' Abortion foes oppose nonprescriptio	A.J. Mullen	-	12/17/2003
1	Barr Begins Detailing SEASONALE(R) to Physicians and Healthcare Providers Tues	A.J. Mullen	-	12/17/2003

Go to reply# or date (mm/dd/yy):